The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zalman, L. S.
Right arrow Articles by Muller-Eberhard, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zalman, L. S.
Right arrow Articles by Muller-Eberhard, H. J.

The Journal of Immunology, Vol 143, Issue 6 1943-1947, Copyright © 1989 by American Association of Immunologists


ARTICLES

Isolation of homologous restriction factor from human urine. Immunochemical properties and biologic activity

LS Zalman, MA Brothers and HJ Muller-Eberhard
Research Institute of Scripps Clinic, Department of Immunology, La Jolla, CA 92037.

A soluble form of homologous restriction factor (HRF-U) was isolated from normal human urine. With respect to m.w. (65,000) and immunoblotting characteristics, it resembled membrane HRF (HRF-M) that had been isolated from human E membranes. The protein exhibited limited cross-reactivity with the channel-forming proteins of C and cytotoxic lymphocytes. It inhibited reactive lysis of E by human C5b-9. Inhibition occurred at the attachment stage of C5b-7 to target cells, rather than at the C8 or C9 stage of membrane attack complex assembly which is inhibited by HRF-M. In this respect, HRF-U acts analogously to S protein of serum, but no immunochemical relationship between these two proteins was detected. HRF-U might be derived from the soluble HRF detected in cytoplasmic granules of killer lymphocytes.


This article has been cited by other articles:


Home page
J. Neurosci.Home page
L.-B. Yang, R. Li, S. Meri, J. Rogers, and Y. Shen
Deficiency of Complement Defense Protein CD59 May Contribute to Neurodegeneration in Alzheimer's Disease
J. Neurosci., October 15, 2000; 20(20): 7505 - 7509.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Acosta, J. Hettinga, R. Fluckiger, N. Krumrei, A. Goldfine, L. Angarita, and J. Halperin
Molecular basis for a link between complement and the vascular complications of diabetes
PNAS, May 9, 2000; 97(10): 5450 - 5455.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.